Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 700 of 1467 entries
View as:

Dermacyd Femina (Lactic Acid) Pocket BR - Photo Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT00783640 Org: User:
Start: 10/31/08 End: - Due: -

Single Dose Clamp Study To Compare Concentration/Time Profile And Metabolic Activity Profile Of 2 New Formulations Of Insulin Glargine With Lantus

Phase: N/A Priority: Normal
NCT ID: NCT02201199 Org: User:
Start: 08/31/14 End: 11/30/14 Due: 11/30/15

32 Week, Open, Randomized, 2 Way Cross Over Multicentre Trial to Compare Safety & Efficacy of Combination of HOE901 Insulin Analogue Once Daily at Bedtime + Lispro Insulin Before Meals vs NPH Insulin (Twice a Day) + Regular in Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00537251 Org: User:
Start: 11/30/01 End: 02/29/04 Due: 02/28/05

Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00816543 Org: User:
Start: 12/31/08 End: 05/31/12 Due: 05/31/13

Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00008281 Org: User:
Start: 10/31/00 End: - Due: -

Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection

Phase: N/A Priority: Normal
NCT ID: NCT01240460 Org: User:
Start: 01/31/11 End: 06/30/12 Due: 06/30/13

Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients

Phase: N/A Priority: Normal
NCT ID: NCT00271323 Org: User:
Start: 05/31/05 End: 02/28/07 Due: 02/28/08

SAR407899 Single-dose in Treatment of Mild to Moderate Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00914277 Org: User:
Start: 05/31/09 End: 10/31/09 Due: 10/31/10

Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01151137 Org: User:
Start: 07/31/10 End: 09/30/11 Due: 09/30/12

DOMME Dose Optimization Multicentric Mexican Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT00488527 Org: User:
Start: 04/30/07 End: 12/31/08 Due: 12/31/09

Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01907685 Org: User:
Start: 06/30/06 End: 02/28/11 Due: 02/28/12

REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents

Phase: N/A Priority: Normal
NCT ID: NCT00546325 Org: User:
Start: 10/31/07 End: 02/28/09 Due: 02/28/10

Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3

Phase: N/A Priority: Normal
NCT ID: NCT03485677 Org: User:
Start: 04/11/18 End: 11/20/25 Due: 11/20/26

Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00044811 Org: User:
Start: 03/31/02 End: 10/31/03 Due: 10/31/04

An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses

Phase: N/A Priority: Normal
NCT ID: NCT00377273 Org: User:
Start: 11/30/03 End: 10/31/05 Due: 10/31/06

Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria

Phase: N/A Priority: Normal
NCT ID: NCT00561964 Org: User:
Start: 01/31/04 End: 07/31/05 Due: 07/31/06

Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy

Phase: N/A Priority: Normal
NCT ID: NCT00283062 Org: User:
Start: 12/31/05 End: 12/31/10 Due: 12/31/11

Sarilumab COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04327388 Org: User:
Start: 03/28/20 End: 09/02/20 Due: 09/02/21

TRACE: Tirapazamine-Radiation And Cisplatin Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT00174837 Org: User:
Start: 04/30/05 End: 01/31/08 Due: 01/31/09

Insulin Glargine "All to Target" Trial

Phase: N/A Priority: Normal
NCT ID: NCT00384085 Org: User:
Start: 05/31/06 End: 03/31/10 Due: 03/31/11

An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00531622 Org: User:
Start: 09/30/07 End: 01/31/09 Due: 01/31/10

Telithromycin in Acute Exacerbation of Chronic Bronchitis

Phase: N/A Priority: Normal
NCT ID: NCT00288223 Org: User:
Start: 01/31/06 End: 01/31/07 Due: 01/31/08

Pilot Study of the Safety & Efficacy of Two Docetaxel-Based Regimens Plus Bevacizumab for the Adjuvant Treatment of Subjects With Node Positive or High Risk Node Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00446030 Org: User:
Start: 03/31/07 End: 08/31/10 Due: 08/31/11

Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00845429 Org: User:
Start: 10/31/07 End: 11/30/08 Due: 11/30/09

A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Phase: N/A Priority: Normal
NCT ID: NCT05726682 Org: User:
Start: 10/08/24 End: 10/11/27 Due: 10/11/28